Get 20% lifetime commission for referring investors to digrin.com
here.
Grace Therapeutics, Inc. ( GRCE) - Stock Earnings
GRCE Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 12, 2026, midnight | — / — | — | — / — | — |
GRCE Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -3.2 million USD | — USD |
| 2026Q1 | -1.2 million USD | — USD |
| 2026Q2 | -15.8 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
GRCE Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | -17.4 million USD | — USD |
| 2025 | -13.6 million USD | — USD |
| 2026 | -7.8 million USD | — USD |
| 2026 Est. | — | — |
GRCE
Price: $1.89
52 week price:
Earnings Per Share: -1.17 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 33.6 million